The use of JHU083 may be a step forward in this regard, since it has a differential effect on cancer cells and T cells; it inhibits a broad range of glutamine-requiring enzymes including glutaminase, and consequently suppresses oxidative and glycolytic metabolism in cancer cells, resulting in decreased hypoxia, acidosis, and nutrient depletion [170]. The gene discussed is GLS; the disease is cancer.